Lantern Pharma stock climbs after LP-184 cancer drug hits trial endpoints

2 months ago 13
Read Entire Article
  1. Homepage
  2. Finance
  3. Lantern Pharma stock climbs after LP-184 cancer drug hits trial endpoints

Related

BHP says no longer seeking Anglo American takeover

BHP says no longer seeking Anglo American takeover

39 minutes ago 2
BHP abandons Anglo American approach, says own growth plan compelling

BHP abandons Anglo American approach, says own growth plan c...

39 minutes ago 2
Macquarie offers to acquire Qube Holdings at enterprise value of $7.49 billion

Macquarie offers to acquire Qube Holdings at enterprise valu...

1 hour ago 4

Trending

1. paul thomas anderson
2. montana
3. mls playoff bracket
4. kevin patullo
5. emeka egbuka
6. ian wright
7. américa de cali vs junior
8. azzi fudd
9. udo kier
10. partridge creek

Popular

College football by the odds: Vegas picks and preview of Ohio State vs. Notre Dame

College football by the odds: Vegas picks and preview of Ohi...

10 months ago 609
What is Tren de Aragua, the Venezuelan gang targeted by Trump?

What is Tren de Aragua, the Venezuelan gang targeted by Trum...

8 months ago 481
Taiwan slightly cuts 2025 GDP growth outlook amid Trump tariffs concern

Taiwan slightly cuts 2025 GDP growth outlook amid Trump tari...

8 months ago 333
What to do in Las Vegas this week: January 2-8

What to do in Las Vegas this week: January 2-8

10 months ago 298
Australian whose blood saved 2.4 million babies dies

Australian whose blood saved 2.4 million babies dies

8 months ago 291
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Sincity Press 2025. All rights are reserved